PRIMA EU Retrospective & Prospective
This clinical study aims at evaluating clinical, radiographic and patient-reported outcomes after total anatomic or reverse shoulder replacement using PRIMA humeral stem up to 24 months after surgery, in order to assess the short-term performance of the implant. Furthermore, the objective is also to collect short-term data on the survivorship of the implant and the incidence of complications.
Age ≥ 18 years old; [+13]
Patients who lack capacity to be able to provide informed consent to participate... [+18]